ORMP News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$173.9M

Volume

262.12K

Next Earnings

November 12th

Chart Financials Earnings News About Dividends Insider Filings

Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® IndexesOramed Pharmaceuticals Inc. (NASDAQ: ORMP) announced it will be added to the Russell 2000® and Russell 3000® indexes following the 2026 semi-annual reconstitution, effective June 29, 2026. The inclusion is based on the company's market capitalization ranking as of April 30, 2026, and will provide automatic inclusion in appropriate growth and value style indexes.Benzinga · Jun 17, 2026

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical CompanyLifeward Ltd. announced shareholder approval for a strategic partnership with Oramed Pharmaceuticals, integrating Oramed's POD™ oral delivery technology platform. The deal provides Lifeward with up to $47 million in capital while allowing the company to diversify from its core medical technology business into biotechnology. Oramed will manage and fund the POD™ platform's clinical development, while Lifeward maintains focus on profitability from its existing ReWalk® and AlterG® product lines.GlobeNewswire Inc. · Mar 13, 2026

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend PaymentsOramed Pharmaceuticals received an $18 million payment from Scilex Holdings, closing out option agreement obligations and bringing total returns to $118 million on its original $99.5 million investment. The company's board approved a $0.25 per share cash dividend (~$10.5 million aggregate) to be paid on January 26, 2026. Oramed retains $39 million in outstanding debt, convertible notes, warrants, and royalty interests with Scilex.Benzinga · Jan 7, 2026

ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTSOramed Pharmaceuticals announced a Rights Plan to protect against hostile takeovers, distributing one common stock purchase right per outstanding share, with rights becoming exercisable if a person/group acquires 15% or more of outstanding stock.Benzinga · Nov 17, 2025

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral InsulinOramed Pharmaceuticals announced a joint venture with Hefei Tianhui Biotech to accelerate the development and commercialization of its oral insulin and other oral drug delivery technologies. The new company, OraTech Pharmaceuticals, will receive significant financial backing and leverage HTIT's manufacturing capabilities.Benzinga · Feb 11, 2025

Top 4 Health Care Stocks That May Crash This QuarterAs of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here’s the latest list of major overbought players in this sector. PepGen Inc. (NASDAQ: PEPG) On Jan. 8, PepGen said First Patient was dosed in CONNECT1-EDO51 Phase 2 clinical trial of PGN-EDO51 for duchenne muscular dystrophy patients amenable to Exon 51 skipping. The company’s stock ...Benzinga · Feb 2, 2024

Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionGainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'. Conformis, Inc. (NASDAQ: CFMS) shares rose 91.3% to $0.2969 after the company agreed to be acquired by restor3d, a leading personalized 3D-printed orthopedic company, for a purchase price of $2.27 per share in cash. SCWorx Corp. (NASDAQ: WORX) gained 62% to $0.5800. OncoSec Medical Incorporated (NASDAQ: ONCS) shares jumped 41.3% to $0.2969 after gaining around 8% on Thursday. Surgalign Holdings, Inc. (NASDAQ: SRGA) shares gained 40.9% to $0.2839. Surgalign received NASDAQ delisting notice following Chapter 11 filing. Nuvve Holding Corp. (NASDAQ: NVVE) shares rose 34% to $0.6101 after the company launched Astrea AI forecasting for Nordic Energy market. Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 24.7% to $0.2749. Smith & Wesson Brands, Inc. (NASDAQ: SWBI) shares climbed 17% to $13.15 as the company reported better-than-expected results for its fourth quarter and raised its quarterly dividend from $0.10 to $0.12 per share. Applied Digital Corporation (NASDAQ: APLD) rose 15.8% to $11.20 after the company announced its AI cloud service has secured a second AI customer with an agreement worth up to $460 million over 36 months. Leafly Holdings, Inc. (NASDAQ: LFLY) gained 13.2% to $0.32. Appreciate Holdings, Inc. (NASDAQ: SFR) jumped 11.7% to $0.38. Trupanion, Inc. (NASDAQ: TRUP) gained 10.4% to $22.71 after California and New York approved the company's requested rate increases. CarMax, Inc. (NYSE: KMX) jumped 10% to $86.14 after the company reported better-than-expected first-quarter EPS and sales results. TRxADE HEALTH, Inc. (NASDAQ:Benzinga · Jun 23, 2023

Dow Tumbles 250 Points; CarMax Posts Upbeat ResultsU.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday. Following the market opening Friday, the Dow traded down 0.74% to 33,695.28 while the NASDAQ fell 0.98% to 13,497.22. The S&P 500, also fell, dropping, 0.78% to 4,347.58. Check This Out: Adobe, Zoom Video And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Utilities shares rose 0.4% on Friday. In trading on Friday, information technology shares dipped by 1.5%. Top Headline CarMax Inc (NYSE: KMX) reported better-than-expected first-quarter results. CarMax reported a first-quarter FY23 sales decline of 17.4% year-on-year to $7.69 billion, beating the analyst consensus of $7.53 billion. Adjusted EPS of $1.16 beat the consensus estimate of $0.79. Equities Trading UP TRxADE HEALTH, Inc. (NASDAQ: MEDS) shares shot up 20% to $8.73. Superlatus, Inc. signed a binding letter of intent to be acquired by TRxADE HEALTH. Shares of Greenpro Capital Corp. (NASDAQ: GRNQ) got a boost, shooting 11% to $2.4792. Smith & Wesson Brands, Inc. (NASDAQ: SWBI) shares were also up, gaining 14% to $12.79 after the company reported a fourth-quarter earnings beat. The company also raised its quarterly dividend. Equities Trading DOWN Beyond ...Benzinga · Jun 23, 2023

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day SessionGainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. 1847 Holdings LLC (NASDAQ: EFSH) gained 64.5% to $0.9050 after the company reported a 27.6% increase in revenue to $15.4 million and achieved profitability for the first quarter. Harbor Custom Development, Inc. (NASDAQ: HCDI) surged 49.5% to $8.97 following first-quarter results. WiSA Technologies, Inc. (NASDAQ: WISA) rose 47.4% to $2.33 after the company signed a Letter of Intent to acquire Comhear. WiSA expects acquisition to be accretive beginning in the fourth quarter and sees FY24 revenue of $10 million to $15 million. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) gained 39% to $3.94 as the company said that its Chinese partner, HTIT, has successfully completed a Phase 3 oral insulin clinical trial and submitted a marketing authorization application in China. LM Funding America, Inc. (NASDAQ: LMFA) jumped 34% to $0.9816 following better-than-expected results for the first quarter. MGO Global, Inc. (NASDAQ: MGOL) shares gained 33.2% to $1.5910. MGO Global is scheduled to host a webcast on May 16, 2023 to discuss recent operational developments and financial results for the first quarter. Xenetic Biosciences, Inc. (NASDAQ: XBIO) jumped 24.8% to $4.12. Xenetic Biosciences recently announced a 1-for-10 reverse stock split. Sarepta Therapeutics, Inc. (NASDAQ: SRPT) gained 24% to $148.99 after the company announced the FDA voted in favor of its gene therapy to treat Duchenne muscular dystrophy late Friday. Multiple analysts raised price targets following the announcement. Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) surged 22% to $2.50. ZK International Group Co., Ltd. (NASDAQ: ZKIN) gained 21.7% to $0.7790. Peraso Inc. (NASDAQ: PRSO) shares climbed 18.1% to $0.4263. Peraso is expected to release its first-quarter financial results on May 15, 2023 after the closing bell. InspireMD, Inc. (NASDAQ: NSPR) jumped 18% to $1.71 as the company announced a ...Benzinga · May 15, 2023

Why Oramed Pharmaceuticals Shares Are Trading Higher TodayOramed Pharmaceuticals Inc (NASDAQ: ORMP) shares are trading higher after its partner completed Phase 3 trials of oral insulin in type 2 diabetes in China under a differentiated study protocol. Hefei Tianhui Biotechnology Co Ltd, a strategic partner of Oramed, is moving toward regulatory approval and has submitted the data to the National Medical Products Administration. Oramed has recently ...Benzinga · May 15, 2023

ORMPOramed Pharmaceuticals Inc.

ORMP

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any ORMP yet.

Related Tickers

Earnings

Dividends

Last · Jan 16

Amount$0.25

Yield6.17%

Annual$0.25

Volume

262.13K

Next Earnings

November 12th